Mithrl builds a scientific decision engine for biopharma and research teams. Its biomedical world model combines validated biological knowledge with each organization’s data, then uses AI agents and workflows to help scientists analyze experiments, assess hypotheses and accelerate drug-discovery decisions; the company is preparing its next-generation platform for broader deployment.
OV
Obvious Ventures
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Obvious Ventures is the firm named as financing lead by Hostie and as an existing backer in GenHealth coverage.
Recorded funding activity
Hostie develops a restaurant concierge. GenHealth automates healthcare administration, while Mithrl builds scientific decision tools and Gritt automates infrastructure work. These companies retain distinct customers and product mechanisms in their announcements.
- Rounds participated in
- 3
- Confirmed lead rounds
- 1 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $147M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionMithrl
$20MSeries A
LeadRadical Numerics
Builds multimodal AI models that read, write, and design across DNA, RNA, and proteins
$50MSeed
Role not disclosedIterative Health
Develops technology and services for clinical research.
$77MSeries C
Role not disclosed